Exclusive

Publication

Byline

Location

NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: PROPOSED COLLECTION: 30-DAY COMMENT REQUEST; THE CLINICAL TRIALS REPORTING PROGRAM (CTRP) DATABASE (NCI); CORRECTION

WASHINGTON, March 10 -- National Institutes of Health has issued a notice called: Proposed Collection: 30-Day Comment Request; The Clinical Trials Reporting Program (CTRP) Database (NCI); Correction. ... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; NOTICE OF CLOSED MEETINGS

WASHINGTON, March 10 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Notice of Closed Meetings. The notice was published in the Federal Register on March 10... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES; AMENDED NOTICE OF MEETING

WASHINGTON, March 10 -- National Institutes of Health has issued a notice called: National Institute of Diabetes and Digestive and Kidney Diseases; Amended Notice of Meeting. The notice was published... Read More


NATIONAL INSTITUTES OF HEALTH ISSUES NOTICE: CENTER FOR SCIENTIFIC REVIEW; AMENDED NOTICE OF MEETING

WASHINGTON, March 10 -- National Institutes of Health has issued a notice called: Center for Scientific Review; Amended Notice of Meeting. The notice was published in the Federal Register on March 10... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: DETERMINATION OF REGULATORY REVIEW PERIOD FOR PURPOSES OF PATENT EXTENSION; AURORA EV-ICD

WASHINGTON, March 10 -- Food and Drug Administration has issued a notice called: Determination of Regulatory Review Period for Purposes of Patent Extension; AURORA EV-ICD. The notice was published in... Read More


FOOD AND DRUG ADMINISTRATION ISSUES NOTICE: NEW AND REVISED DRAFT Q&AS ON BIOSIMILAR DEVELOPMENT AND THE BIOLOGICS PRICE COMPETITION AND INNOVATION ACT; DRAFT GUIDANCE FOR INDUSTRY; AVAILABILITY

WASHINGTON, March 10 -- Food and Drug Administration has issued a notice called: New and Revised Draft Q&As on Biosimilar Development and the Biologics Price Competition and Innovation Act; Draft Guid... Read More


ADMINISTRATION FOR CHILDREN AND FAMILIES ISSUES NOTICE: SUBMISSION FOR OFFICE OF MANAGEMENT AND BUDGET REVIEW; TITLE CENTRAL AUTHORITY PAYMENT SERVICE (NEW COLLECTION)

WASHINGTON, March 10 -- Administration for Children and Families has issued a notice called: Submission for Office of Management and Budget Review; Title Central Authority Payment Service (New Collect... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: AGENCY INFORMATION COLLECTION ACTIVITIES: PROPOSED COLLECTION; COMMENT REQUEST

WASHINGTON, March 10 -- Centers for Medicare & Medicaid Services has issued a notice called: Agency Information Collection Activities: Proposed Collection; Comment Request. The notice was published i... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: MEDICARE PROGRAM; REQUEST FOR RENEWAL OF DEEMING AUTHORITY OF THE NATIONAL COMMITTEE FOR QUALITY ASSURANCE (NCQA) FOR MEDICARE ADVANTAGE HEALTH MAINTENANCE ORGANIZATIONS AND PREFERRED PROVIDER ORGANIZATIONS

WASHINGTON, March 10 -- Centers for Medicare & Medicaid Services has issued a notice called: Medicare Program; Request for Renewal of Deeming Authority of the National Committee for Quality Assurance ... Read More


CENTERS FOR MEDICARE & MEDICAID SERVICES ISSUES NOTICE: MEDICARE AND MEDICAID PROGRAMS: APPLICATION FROM THE AMERICAN ASSOCIATION FOR ACCREDITATION OF AMBULATORY SURGERY FACILITIES FOR CONTINUED CMS-APPROVAL OF ITS RURAL HEALTH CLINIC (RHC) ACCREDITATION PROGRAM

WASHINGTON, March 10 -- Centers for Medicare & Medicaid Services has issued a notice called: Medicare and Medicaid Programs: Application From the American Association for Accreditation of Ambulatory S... Read More